IMAGING AND CLINICAL FEATURES OF PULSATILE POLYPOIDAL CHOROIDAL VASCULOPATHY
Authors:
- 1 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 44 (6) , 1083-1091
Abstract
Purpose: To investigate the imaging and clinical features of polypoidal choroidal vasculopathy (PCV) with pulsation. Methods: The PCV eyes were classified into pulsatile and nonpulsatile PCV groups according to the pulsation on indocyanine green angiography. Imaging features including the dye filling time of the polyp and clinical features were compared. Results: A total of 75 eyes were classified into the pulsatile PCV (30 eyes) and the nonpulsatile PCV (45 eyes) groups. The initial filling time and complete filling time of the polyp of the pulsatile PCV group (2.59 ± 0.93 and 8.33 ± 3.42 seconds) were shorter than those of the nonpulsatile PCV group (4.11 ± 1.87 and 10.63 ± 3.81 seconds, P < 0.001 and P = 0.010, respectively). The pigment epithelial detachment height of the pulsatile PCV group (414.90 ± 377.15 µm) was greater than that of the nonpulsatile PCV group (247.81 ± 164.07 µm, P = 0.030). The pulsatile PCV group showed a higher prevalence of subretinal hemorrhage (43.33%) after intravitreal injection than the nonpulsatile PCV group (13.95%, P = 0.005) during 12 months. The mean number of injections during 12 months of the pulsatile PCV group (5.48 ± 1.46) was greater than that of the nonpulsatile PCV group (4.09 ± 1.21, P < 0.001). Conclusion: Eyes with pulsatile PCV showed shorter filling time of the polyp, greater pigment epithelial detachment height, higher prevalence of subretinal hemorrhage, and more intravitreal injection numbers during 12 months. These might suggest that PCV has distinct imaging and clinical features according to the polyp pulsation.Keywords
Funding Information
- Alumni Department of Ophthalmology, Korea University College of Medicine (N/A)
This publication has 29 references indexed in Scilit:
- Clinicopathological study of the polypoidal lesions of polypoidal choroidal vasculopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2022
- Polypoidal Choroidal VasculopathyOphthalmology, 2021
- Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapyGraefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degenerationGraefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Indocyanine Green Dye Filling Time for Polypoidal Lesions in Polypoidal Choroidal Vasculopathy Affects the Visibility of the Lesions on OCT AngiographyOphthalmology Retina, 2018
- Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapyGraefe's Archive for Clinical and Experimental Ophthalmology, 2013
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO StudyAmerican Journal of Ophthalmology, 2009
- Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patientsJapanese Journal of Ophthalmology, 2008
- Pulsatile Blood Flow in the Polypoidal Choroidal VasculopathyOphthalmology, 2005
- The Expanding Clinical Spectrum of Idiopathic Polypoidal Choroidal VasculopathyArchives of Ophthalmology (1950), 1997